The Covid-19 Pandemic Has Dramatically Changed How Biopharma Does Business See how Jose-Carlos Gutierrez-Ramos, the new Chief Scientific Officer of Danaher, is working to break industry bottlenecks and bring biopharma innovation into the post-Covid era.